股東
Camilla Sylvest
Executive vice president, Commercial Strategy & Corporate Affairs
David Moore
Executive vice president, U.S. Operations & Business Development
Henrik Wulff
Executive vice president, Product Supply, Quality & IT
Karsten Munk Knudsen
Executive vice president and chief financial officer
Lars Fruergaard Jorgensen
President and chief executive officer
Ludovic Helfgott
Executive vice president, Rare disease
Marcus Schindler
Executive vice president, Research & Early Development and chief scientific officer
Martin Holst Lange
Executive vice president, Development
Maziar Mike Doustdar
Executive vice president, International Operations
Tania Sabroe
Executive vice president, People & Organisation